Platelets in the perspective of COVID-19; pathophysiology of thrombocytopenia and its implication as prognostic and therapeutic opportunity

M Delshad, A Safaroghli-Azar… - International …, 2021 - Elsevier
Despite endorsed and exponential research to improve diagnostic and therapeutic
strategies, efforts have not yet converted into a better prospect for patients infected with the …

Role of red blood cell distribution width, as a prognostic indicator in COVID‐19: a systematic review and meta‐analysis

S Sarkar, S Kannan, P Khanna… - Reviews in Medical …, 2022 - Wiley Online Library
The red blood cell distribution width (RDW), an indicator of anisocytosis has emerged as a
potential tool for risk stratification of critically ill patients with sepsis. Prognostic predictors are …

Pathological effects of SARS-CoV-2 on hematological and immunological cells: Alterations in count, morphology, and function

E Ahmadi, Z Bagherpour, E Zarei… - Pathology-Research and …, 2022 - Elsevier
Abstract The novel Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), the
causative agent of COVID-19 outbreak, spread rapidly and infected more than 140 million …

Significance of MPV, RDW and PDW with the Severity and Mortality of COVID-19 and Effects of Acetylsalicylic Acid Use

F Aydınyılmaz, E Aksakal… - Clinical and Applied …, 2021 - journals.sagepub.com
We aimed to investigate association between mean platelet volume (MVP), platelet
distribution width (PDW) and red cell distribution width (RDW) and mortality in patients with …

Platelet distribution width (PDW) as a significant correlate of COVID-19 infection severity and mortality

D Ligi, C Della Franca, KI Notarte… - Clinical Chemistry and …, 2024 - degruyter.com
SARS-CoV-2 infection may cause a wide spectrum of symptoms, from asymptomatic, to mild
respiratory symptoms and life-threatening sepsis. Among the clinical laboratory biomarkers …

Mean platelet volume as a predictor of COVID-19 severity: a prospective cohort study in the Highlands of Peru

JF Quispe-Pari, JA Gonzales-Zamora… - Diseases, 2022 - mdpi.com
Introduction: Although 80% of symptomatic individuals with COVID-19 develop mild forms, it
is the severe (15%) and critical (5%) forms that have the greatest impact in the hospital …

Evaluation of hematological parameters and inflammatory markers in children with COVID-19

G Alkan, A Sert, M Emiroglu, SK Tuter Oz… - Irish Journal of Medical …, 2021 - Springer
Background The aim of this study was to evaluate hematological parameters in children with
COVID-19 and determine the effects of inflammatory biomarkers on the assessment of …

Transforming growth factor beta 1 (TGF-β1) in COVID-19 patients: relation to platelets and association with the disease outcome

S Zivancevic-Simonovic, R Minic, V Cupurdija… - Molecular and Cellular …, 2023 - Springer
Transforming growth factor beta (TGF-β) is a ubiquitously distributed cytokine known to
contribute to the pathogenesis of numerous pathological processes. The aim of this study …

A complete blood count-based multivariate model for predicting the recovery of patients with moderate COVID-19: a retrospective study

Y Wang, X Li, J Xu, Q Zhou - Scientific reports, 2022 - nature.com
Many resource-limited countries need an efficient and convenient method to assess disease
progression in patients with coronavirus disease 2019 (COVID-19). This study developed …

Clinical utility of haematological inflammatory biomarkers in predicting 30‐day mortality in hospitalised adult patients with COVID‐19

A Embaby, MG Hamed, H Ebian… - British Journal of …, 2023 - Wiley Online Library
Summary Coronavirus disease 2019 (COVID‐19) is a multisystem disease affecting
respiratory, cardiovascular, gastrointestinal, neurological, immunological and …